Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Ventyx Biosciences, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2023 |
4
| Mohan Raju (CEO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 30,000 shares
@ $29.1077, valued at
$873.2k
Exercised 30,000 options to buy
@ $8.04, valued at
$241.2k
|
|
| 10/04/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 14,006 shares
@ $29.9291, valued at
$419.2k
Sold 994 shares
@ $30.6959, valued at
$30.5k
Exercised 15,000 options to buy
@ $8.04, valued at
$120.6k
|
|
| 10/04/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 9,277 shares
@ $29.937, valued at
$277.7k
Sold 723 shares
@ $30.7155, valued at
$22.2k
Exercised 1,401 options to buy
@ $0.2, valued at
$280.2
Exercised 7,972 options to buy
@ $3.54, valued at
$28.2k
Exercised 627 options to buy
@ $8.04, valued at
$5k
|
|
| 08/08/2023 |
4
| Sandborn William J. (See Remarks) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 2,086 shares
@ $32.6852, valued at
$68.2k
Sold 1,408 shares
@ $33.1167, valued at
$46.6k
|
|
| 08/08/2023 |
4
| Mohan Raju (CEO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 20,225 shares
@ $33.2017, valued at
$671.5k
Sold 8,898 shares
@ $34.0938, valued at
$303.4k
Sold 877 shares
@ $35.005, valued at
$30.7k
Exercised 30,000 options to buy
@ $8.04, valued at
$241.2k
|
|
| 08/04/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 8,887 shares
@ $35.5587, valued at
$316k
Sold 1,113 shares
@ $35.9171, valued at
$40k
Exercised 10,000 options to buy
@ $0.2, valued at
$2k
|
|
| 08/04/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 13,300 shares
@ $35.5452, valued at
$472.8k
Sold 1,700 shares
@ $35.9094, valued at
$61k
Exercised 15,000 options to buy
@ $8.04, valued at
$120.6k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| NSV Partners III LP (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 28,646 shares
@ $37.5414, valued at
$1.1M
Sold 3,275 shares
@ $37.6242, valued at
$123.2k
|
|
| 07/13/2023 |
4
| Subramaniam Somu (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 28,646 shares
@ $37.5414, valued at
$1.1M
Sold 3,275 shares
@ $37.6242, valued at
$123.2k
|
|
| 07/11/2023 |
4
| Subramaniam Somu (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 75,686 shares
@ $34.9879, valued at
$2.6M
Sold 20,718 shares
@ $35.8225, valued at
$742.2k
Sold 3,596 shares
@ $36.9277, valued at
$132.8k
Disposed of 1,030,341 shares
@ $0 |
|
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| NSV Partners III LP (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 5,043 shares
@ $35.4797, valued at
$178.9k
Sold 11,256 shares
@ $36.781, valued at
$414k
Sold 14,331 shares
@ $37.6378, valued at
$539.4k
Sold 22,568 shares
@ $39.0452, valued at
$881.2k
Sold 80,882 shares
@ $39.7642, valued at
$3.2M
|
|
| 07/06/2023 |
4
| Subramaniam Somu (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 5,043 shares
@ $35.4797, valued at
$178.9k
Sold 11,256 shares
@ $36.781, valued at
$414k
Sold 14,331 shares
@ $37.6378, valued at
$539.4k
Sold 22,568 shares
@ $39.0452, valued at
$881.2k
Sold 80,882 shares
@ $39.7642, valued at
$3.2M
|
|
| 07/05/2023 |
4
| Mohan Raju (CEO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 17,298 shares
@ $37.7438, valued at
$652.9k
Sold 6,659 shares
@ $38.7798, valued at
$258.2k
Sold 5,920 shares
@ $39.7199, valued at
$235.1k
Sold 123 shares
@ $40.315, valued at
$5k
Exercised 29,785 options to buy
@ $8.04, valued at
$239.5k
|
|
| 07/05/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 327 shares
@ $33.5442, valued at
$11k
Sold 142 shares
@ $34.7231, valued at
$4.9k
Sold 20 shares
@ $35.2737, valued at
$705.5
Sold 2,266 shares
@ $38.3193, valued at
$86.8k
Sold 1,563 shares
@ $39.3348, valued at
$61.5k
Sold 15,682 shares
@ $39.9643, valued at
$626.7k
Exercised 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 07/05/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Exercised 1,089 shares
@ $8.04, valued at
$8.8k
Exercised 13,911 shares
@ $0.2, valued at
$2.8k
Sold 403 shares
@ $33.5671, valued at
$13.5k
Sold 214 shares
@ $34.722, valued at
$7.4k
Sold 40 shares
@ $35.497, valued at
$1.4k
Sold 1,960 shares
@ $38.0477, valued at
$74.6k
Sold 2,150 shares
@ $38.7903, valued at
$83.4k
Sold 10,233 shares
@ $39.8703, valued at
$408k
Exercised 1,089 options to buy
@ $8.04, valued at
$8.8k
Exercised 13,911 options to buy
@ $0.2, valued at
$2.8k
|
|
| 07/05/2023 |
4
| Sandborn William J. (See Remarks) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 11,900 shares
@ $40.0012, valued at
$476k
Sold 3,487 shares
@ $40, valued at
$139.5k
Exercised 11,900 options to buy
@ $14.85, valued at
$176.7k
|
|
| 06/16/2023 |
4
| Sandborn William J. (See Remarks) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 2,383 shares
@ $33.8774, valued at
$80.7k
Sold 1,104 shares
@ $34.7484, valued at
$38.4k
|
|
| 06/16/2023 |
4
| Cadoret-Manier Onaiza (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/16/2023 |
4
| HULME ALLISON (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/16/2023 |
4
| Subramaniam Somu (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 50,000 shares
@ $35.0757, valued at
$1.8M
|
|
| 06/16/2023 |
4
| NSV Partners III LP (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 50,000 shares
@ $35.0757, valued at
$1.8M
|
|
| 06/12/2023 |
4
| Gujrathi Sheila (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/12/2023 |
4
| Subramaniam Somu (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/12/2023 |
4
| White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/08/2023 |
4
| Subramaniam Somu (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 4,128 shares
@ $35.0003, valued at
$144.5k
Sold 25,801 shares
@ $35.4846, valued at
$915.5k
Sold 10,071 shares
@ $36.1007, valued at
$363.6k
|
|
| 06/08/2023 |
4
| NSV Partners III LP (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 4,128 shares
@ $35.0003, valued at
$144.5k
Sold 25,801 shares
@ $35.4846, valued at
$915.5k
Sold 10,071 shares
@ $36.1007, valued at
$363.6k
|
|
| 06/07/2023 |
4
| Nuss John (Chief Scientific Officer) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 8,322 shares
@ $34.287, valued at
$285.3k
Sold 1,678 shares
@ $34.6429, valued at
$58.1k
Exercised 10,000 options to buy
@ $0.2, valued at
$2k
|
|
|
|
|